Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006. An increasingly popular option among retail and institutional investors ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector uncertainty lasts. On March 31, Paul Matteis appeared on CNBC’s ‘The Exchange ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter's winners and losers.

Access our live advanced streaming chart for the iShares Nasdaq Biotechnology ETF free of charge to monitor the movements of the ETF in real-time. This 'area' or candle chart lets investors spot clear ...

By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers ...

A summary for the SPDR S&P Biotech ETF technical analysis data. Live signals range from strong buy, buy, neutral, sell to strong sell. Assess XBI's detailed technical analysis based on the buy/sell ...